Anna Esteve

1.1k total citations
37 papers, 392 citations indexed

About

Anna Esteve is a scholar working on Oncology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Anna Esteve has authored 37 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Infectious Diseases and 11 papers in Epidemiology. Recurrent topics in Anna Esteve's work include HIV/AIDS Research and Interventions (11 papers), Sex work and related issues (6 papers) and HIV/AIDS drug development and treatment (6 papers). Anna Esteve is often cited by papers focused on HIV/AIDS Research and Interventions (11 papers), Sex work and related issues (6 papers) and HIV/AIDS drug development and treatment (6 papers). Anna Esteve collaborates with scholars based in Spain, United Kingdom and United States. Anna Esteve's co-authors include Jordi Casabona, Denise Whitby, Cinta Folch, Gemma Gambús, Cristina Tural, Thomas F. Schulz, Elisa Martró, Bonaventura Clotet, Jordi Casabona and Elena Ferrer and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Anna Esteve

34 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Esteve Spain	13	235	211	135	96	53	37	392
Romain Palich France	13	327 1.4×	141 0.7×	107 0.8×	127 1.3×	26 0.5×	70	493
Ana María Caro-Murillo Spain	8	145 0.6×	128 0.6×	127 0.9×	74 0.8×	25 0.5×	13	302
Suzanne Fiorillo United States	11	137 0.6×	110 0.5×	123 0.9×	58 0.6×	9 0.2×	19	386
Melanie Middleton Australia	9	106 0.5×	175 0.8×	70 0.5×	41 0.4×	34 0.6×	11	322
Iain Reeves United Kingdom	12	173 0.7×	220 1.0×	43 0.3×	34 0.4×	37 0.7×	29	357
Magid Herida France	6	103 0.4×	135 0.6×	195 1.4×	28 0.3×	20 0.4×	6	336
Thinh N. Le Canada	12	248 1.1×	177 0.8×	53 0.4×	172 1.8×	15 0.3×	15	393
Manuela Bonmarchand France	13	512 2.2×	337 1.6×	164 1.2×	406 4.2×	49 0.9×	18	852
X. de la Tribonnière France	12	256 1.1×	172 0.8×	44 0.3×	137 1.4×	13 0.2×	40	545
Mira Hleyhel Lebanon	9	98 0.4×	110 0.5×	163 1.2×	23 0.2×	16 0.3×	25	343

Countries citing papers authored by Anna Esteve

Since Specialization

Citations

This map shows the geographic impact of Anna Esteve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Esteve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Esteve more than expected).

Fields of papers citing papers by Anna Esteve

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Esteve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Esteve. The network helps show where Anna Esteve may publish in the future.

Co-authorship network of co-authors of Anna Esteve

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Esteve. A scholar is included among the top collaborators of Anna Esteve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Esteve. Anna Esteve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Muñoz‐Mármol, Ana M, Bárbara Meléndez, Ainhoa Hernández, et al.. (2025). Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib. Cancers. 17(3). 375–375. 2 indexed citations

Cirauqui, Beatriz, José Luis Ramírez, Vanesa García‐Barberán, et al.. (2024). Deciphering the impact of STAT3 activation mediated by PTPRT promoter hypermethylation as biomarker of response to paclitaxel‐plus‐cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Head & Neck. 47(1). 57–67.

Villà, S., Carles Majós, Albert Pons‐Escoda, et al.. (2024). Salvage reirradiation for recurrent glioblastoma: a retrospective case series analysis. Clinical & Translational Oncology. 27(5). 2104–2112.

Esteve, Anna, et al.. (2024). Real‐world treatment outcomes of immune checkpoint inhibitors used off‐label in oncology: A comprehensive cancer institution experience. Pharmacology Research & Perspectives. 12(1). e1167–e1167. 2 indexed citations

Pineda, Estela, Ainhoa Hernández, Marta Doménech, et al.. (2024). The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation. Cancers. 16(4). 735–735. 1 indexed citations

Pernas, Sònia, Raül Rigo‐Bonnin, Àlex Teulé, et al.. (2024). Everolimus Through Plasmatic Concentrations in Cancer Patients: Prospective Longitudinal Observational Multicentric Study (DIANA-1 Project). Journal of Clinical Medicine. 14(1). 145–145. 1 indexed citations

Carcereny, Enric, Maria Saigí, Anna Esteve, et al.. (2023). P1.21-04 Role of HLA-I as a Molecular Prognostic Factor for Long Term Responders in Non-small Cell Lung Cancer Patients Treated with Immunotherapy. Journal of Thoracic Oncology. 18(11). S235–S235. 1 indexed citations

Plaja, Andrea, María Ochoa-de-Olza, Marc Cucurull, et al.. (2023). Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery. International Journal of Molecular Sciences. 24(14). 11420–11420. 3 indexed citations

Esteve, Anna, et al.. (2023). Real‐world treatment outcomes of medicines used in special situations (off‐label and compassionate use) in oncology and hematology: A retrospective study from a comprehensive cancer institution. Cancer Medicine. 12(16). 17112–17125. 3 indexed citations

10.

Cucurull, Marc, Carolina Sanz, Enric Carcereny, et al.. (2023). Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C. Frontiers in Oncology. 13. 1239000–1239000. 2 indexed citations

11.

Font, Albert, Montserrat Domènech, Xavier Elias, et al.. (2022). Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancer. World Journal of Urology. 40(11). 2627–2634. 1 indexed citations

12.

Esteve, Anna, Aída Selfa Muñoz, Jorge Abad, et al.. (2021). Prospective pilot study to explore the melatonin level in brain tumor patients undergoing radiotherapy. Sleep And Breathing. 26(1). 469–475. 4 indexed citations

13.

Piulats, Josep M., Núria Sala, A. Boladeras, et al.. (2020). 667P Impact of pretreatment neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) on overall survival (OS) in patients (p) with metastatic castration-sensitive prostate cancer (mCSPC) treated with docetaxel (D) plus androgen-deprivation therapy (ADT). Annals of Oncology. 31. S537–S537. 2 indexed citations

14.

Plana, Nieves, Anna Esteve, Marc Oliva, et al.. (2020). 949P Impact of antibiotic use and derived neutrophil to lymphocyte ratio (dNLR) in patients with recurrent/metastatic head and neck squamous cell cancer (R/M HNSCC) treated with immunotherapy. Annals of Oncology. 31. S675–S675. 2 indexed citations

15.

Conway, Anna, et al.. (2018). Determinants and Outcomes of Late Presentation of HIV Infection in Migrants in Catalonia, Spain: PISCIS Cohort 2004–2016. Journal of Immigrant and Minority Health. 21(5). 920–930. 5 indexed citations

16.

Campbell, Colin, Juan Ambrosioni, José M. Miró, et al.. (2015). The continuum of HIV care in Catalonia. AIDS Care. 27(12). 1449–1454. 12 indexed citations

17.

Manzardo, Christian, Anna Esteve, D Podzamczer, et al.. (2012). Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS Cohort. Clinical Microbiology and Infection. 19(7). 646–653. 13 indexed citations

18.

Jaén, Ángeles, Anna Esteve, Josep M. Miró, et al.. (2008). Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2). 212–220. 44 indexed citations

19.

Darwich, Laila, Anna Esteve, Lı́dia Ruiz, et al.. (2008). Drug-Resistance Mutations Number and K70R or T215Y/F Substitutions Predict Treatment Resumption during Guided Treatment Interruptions. AIDS Research and Human Retroviruses. 24(5). 725–732. 4 indexed citations

20.

González, Victoria, Elisa Martró, Cinta Folch, et al.. (2007). Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies. European Journal of Clinical Microbiology & Infectious Diseases. 27(2). 121–126. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact